13F Data
Security · CUSIP 15117B103

CELLDEX THERAPEUTICS

COM · institutional ownership from 13F filings
13F holders
0
Shares held
0
Value held
$0
New / sold out
0 / 1
Added / reduced
0 / 0
net -86 shares

13F holders by quarter

Q2 2013: 126Q3 2013: 148Q4 2013: 158Q1 2014: 156Q2 2014: 135Q3 2014: 148Q4 2014: 163Q1 2015: 193Q2 2015: 186Q3 2015: 163Q4 2015: 172Q1 2016: 146Q2 2016: 141Q3 2016: 137Q4 2016: 141Q1 2017: 134Q2 2017: 130Q3 2017: 129Q4 2017: 135Q1 2018: 131Q2 2018: 102Q3 2018: 96Q4 2018: 85Q1 2019: 2Q2 2019: 2Q3 2019: 2Q4 2019: 2Q1 2020: 2Q2 2020: 2Q3 2020: 0Q3 2023: 1Q4 2023: 0
Q2 2013Q4 2023

Net shares bought by existing holders

Q2 2013: 0Q3 2013: 4.7MQ4 2013: 10.5MQ1 2014: 2.1MQ2 2014: 7.5MQ3 2014: -5.8MQ4 2014: 1.6MQ1 2015: 6.2MQ2 2015: 154.9KQ3 2015: 526.1KQ4 2015: 10.7MQ1 2016: -12.8MQ2 2016: -5.9MQ3 2016: -10.3MQ4 2016: 13.4MQ1 2017: 6.6MQ2 2017: -8.5MQ3 2017: -1.3MQ4 2017: 6.9MQ1 2018: 6.9MQ2 2018: -17.2MQ3 2018: -7.1MQ4 2018: -4.4MQ1 2019: -51.9MQ2 2019: 0Q3 2019: 0Q4 2019: 0Q1 2020: 0Q2 2020: -104.0KQ3 2020: -316.8KQ3 2023: 86Q4 2023: -86
Q2 2013Q4 2023

Top holders · Q4 2023

Nothing to show.

Biggest buyers

Nothing to show.

Biggest sellers

ManagerChangeShares changeChange %
Byrne Asset Management LLCSold out-86-100.0%